Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05065918 · ClinicalTrials.gov registry record · NA
Text Message Intervention for Alcohol Use and Sexual Violence in College Students
A NA study of Alcohol Use, Unspecified and Sexual Assault, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
- 1
- Study location
NCT05065918: Completed NA study of Alcohol Use, Unspecified and Sexual Assault, sponsored by University of Arkansas.
NCT05065918 is a NA study of Alcohol Use, Unspecified and Sexual Assault that has completed, run by University of Arkansas. The registered enrollment target is 183 participants, below the 252-participant average among 13 other Alcohol Use, Unspecified trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05065918, a NA study of Alcohol Use, Unspecified and Sexual Assault, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to pilot a text message (TM) delivered behavior change intervention to decrease binge drinking and to increase use of sexual violence (SV) harm reduction strategies among college students.
Primary Outcome
as measured using a 30-day timeline follow-back (TLFB)
Conditions Studied
Interventions
- BEHAVIORAL sexual violence and alcohol use harm reduction text message content
- BEHAVIORAL alcohol use reduction content
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2021-11-04 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
What the finished NCT05065918 record still lists
NCT05065918 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 252-participant average among 13 other Alcohol Use, Unspecified trials with a reported enrollment target (27% lower).
The record links to 3 conditions, with Alcohol Use, Unspecified appearing as the primary indexed condition, and to 2 interventions - of which sexual violence and alcohol use harm reduction text message content is the first listed.
NCT05065918 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT05065918 about?
NCT05065918 is a clinical study titled "Text Message Intervention for Alcohol Use and Sexual Violence in College Students". This study is designed to pilot a text message (TM) delivered behavior change intervention to decrease binge drinking and to increase use of sexual violence (SV) harm reduction strategies among college students.
What is the current status of trial NCT05065918?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2021-11-04. Estimated completion is 2023-08-31.
What conditions does trial NCT05065918 study?
This clinical trial studies the following conditions: Alcohol Use, Unspecified, Sexual Assault, Sexual Violence.
What interventions are being tested in trial NCT05065918?
The interventions under investigation include: sexual violence and alcohol use harm reduction text message content (BEHAVIORAL), alcohol use reduction content (BEHAVIORAL).
Who is sponsoring clinical trial NCT05065918?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05065918 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use, Unspecified
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05065918's enrollment target sits among peer trials
183 6th of 13 higher than 8 of 13 other Alcohol Use, Unspecified trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use, Unspecified trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
RECRUITING · NA
-
Optimizing a Digital AEP Risk Intervention With Native Women and Communities
RECRUITING · NA
-
Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care
RECRUITING · NA
-
Drinking, Acetate, and Stress
RECRUITING · NA
-
Partnering to Enhance Emerging Adults' Response to Programs
RECRUITING · NA
-
CARS: Cannabis and Alcohol Reduction Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI